ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 239 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2021. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $4,899,602 | +46.9% | 104,939 | +50.5% | 0.00% | +33.3% |
| Q4 2023 | $3,335,254 | -29.7% | 69,746 | -47.6% | 0.00% | -25.0% |
| Q3 2023 | $4,740,951 | +0.1% | 132,986 | +29.6% | 0.00% | 0.0% |
| Q2 2023 | $4,735,014 | +71.9% | 102,645 | +49.5% | 0.00% | +33.3% |
| Q1 2023 | $2,753,908 | +49.4% | 68,676 | +72.6% | 0.00% | +50.0% |
| Q4 2022 | $1,843,286 | -12.9% | 39,786 | +114.1% | 0.00% | 0.0% |
| Q1 2021 | $2,116,000 | -37.9% | 18,585 | -24.5% | 0.00% | -50.0% |
| Q4 2020 | $3,409,000 | +53.6% | 24,627 | -8.8% | 0.00% | +33.3% |
| Q3 2020 | $2,219,000 | +41.9% | 27,000 | +35.0% | 0.00% | +50.0% |
| Q2 2020 | $1,564,000 | +60.1% | 20,000 | -9.1% | 0.00% | +100.0% |
| Q1 2020 | $977,000 | – | 22,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 217,459 | $24,760,000 | 1.64% |
| Motley Fool Asset Management LLC | 152,326 | $17,344,000 | 1.25% |
| Rock Springs Capital Management LP | 450,000 | $51,237,000 | 1.12% |
| AtonRa Partners | 21,017 | $2,393,000 | 1.07% |
| SECTORAL ASSET MANAGEMENT INC | 112,200 | $12,775,000 | 0.97% |
| EMERALD ADVISERS, LLC | 228,368 | $26,002,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 239,023 | $27,215,000 | 0.90% |
| FEDERATED HERMES, INC. | 3,912,408 | $445,467,000 | 0.86% |
| HealthCor Management, L.P. | 207,610 | $23,638,000 | 0.84% |
| Atika Capital Management LLC | 66,000 | $7,515,000 | 0.65% |